Postangioplasty restenosis: Platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis
- 1 April 1997
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 133 (4) , 387-392
- https://doi.org/10.1016/s0002-8703(97)70178-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Haemostatic variables in patients with unstable anginaInternational Journal of Cardiology, 1994
- Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin.Circulation Research, 1993
- Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent plateletsNature, 1992
- A monoclonal antibody-based enzyme immunoassay for human GMP-140/P-selectinJournal of Immunological Methods, 1992
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- Rapid neutrophil adhesion to activated endothelium mediated by GMP-140Nature, 1990
- PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytesCell, 1989
- GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.Journal of Clinical Investigation, 1989
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984